Fig. 3From: Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age – a multicenter retrospective studyEffects of everolimus treatment. CR cardiac rhabdomyoma. SEGA subependymal giant cell astrocytoma.Back to article page